tradmap

NUS Financials NU SKIN ENTERPRISES, INC.

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has declined 10.5% per year over the past 5 years.
  • Net income has grown faster than revenue (-3.5% vs -10.5% per year).
  • Operating margin has contracted, at 4.4% in the latest year.
  • Free cash flow has declined 32.0% per year over the past 5 years.

Financial health

  • The company holds more cash ($239M) than total debt ($224M).
  • Total debt has grown in line with revenue (-7.7% vs -10.5% per year).
  • Operating income covered interest expense 4.7× in the latest year.
  • Total debt is 1.9× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 7.4% of earnings and 25.7% of free cash flow.
  • The dividend has declined 31.5% per year over the past 5 years.
Revenue & net income
-$147M $1B $3B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-9% 35% 78% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $173M $345M 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $263M $525M 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$245M $143M $530M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $1.5B $160M 69.4% 4.4% $46M $224M $239M
2024 $1.7B -$147M 68.2% -8.8% $70M $394M $187M
2023 $2.0B $9M 68.9% 2.5% $60M $503M $256M
2022 $2.2B $105M 71.7% 5.0% $49M $402M $265M
2021 $2.7B $147M 75.0% 8.7% $73M $376M $340M
2020 $2.6B $191M 74.5% 10.0% $315M $335M $403M
2019 $2.4B $174M 76.0% 11.0% $112M $362M $336M
2018 $2.7B $122M 76.3% 9.0% $132M $430M $387M
2017 $2.3B $129M 78.0% 12.0% $242M $389M $426M
2016 $2.2B $143M 77.3% 10.5% $225M $417M $357M
2015 — $133M — — $265M $254M $289M
2014 — $189M — — — $253M $288M
2013 — $365M — — $345M $182M $525M
2012 — $222M — — $214M $194M $320M
2011 — $153M — — $183M $137M $273M

Valuation over time

How the market has priced NUS against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 52.4 104.8 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 0.4 0.9 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 12.9 25.8 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is NUS growing its revenue and profit?

Over the past 5 years, NU SKIN ENTERPRISES, INC.'s revenue has declined 10.5% per year, and net income declined 3.5% per year. These are computed facts, not advice.

How much debt does NUS have?

As of FY2025, NU SKIN ENTERPRISES, INC. reported $224M of total debt against $239M of cash; operating income covered interest expense 4.7×.

What is NUS's profit margin?

In FY2025, gross margin was 69.4%, operating margin 4.4%, and net margin 10.8%.

What is NUS's P/E ratio?

As of Jun '26, NU SKIN ENTERPRISES, INC. traded at a price-to-earnings ratio of about 1.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.